Deciphera Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
Deciphera Pharmaceuticals, Inc. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of -$36.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2018-05-08
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2018-03-31 was -$36.00K.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was -$51.00K.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2017 was $176.40M, a 220.75% increase from fiscal 2016.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $55.00M, a 43.15% increase from fiscal 2015.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $38.42M.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|
| 2018-03-31 | -$36.00K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $176.40M 10-K · filed 2018-03-28 | |
| 2017-03-31 | -$51.00K 10-Q · filed 2018-05-08 | |
| 2016-12-31 | $55.00M 10-K · filed 2018-03-28 | |
| 2015-12-31 | $38.42M 10-K · filed 2018-03-28 |